|   |   | 
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/445 | (2006.01) | 
| C07D 211/60 | (2013.01) | ||
| C07D 211/60 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 9/10 | (2018.01) | 
| (11) | Patento numeris | 3682879 | 
| (13) | Dokumento rūšis | T | 
| (96) | Europos patento paraiškos numeris | 20160995.5 | 
| Europos patento paraiškos padavimo data | 2015-09-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-07-22 | 
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-08-03 | 
| (46) | Apibrėžties vertimo paskelbimo data | 
| (30) | Numeris | Data | Šalis | 
| 201462057107 P | 2014-09-29 | US | 
| (72) | 
                    
                    
                    
                    
                    FAN, Pingchen , US  
                    
                    
                    
                    
                    KALISIAK, Jaroslaw , US  
                    
                    
                    
                    
                    KRASINSKI, Antoni , US  
                    
                    
                    
                    
                    LUI, Rebecca , US  
                    
                    
                    
                    
                    POWERS, Jay , US  
                    
                    
                    
                    
                    PUNNA, Sreenivas , US  
                    
                    
                    
                    
                    TANAKA, Hiroko , US  
                    
                    
                    
                    
                    ZHANG, Penglie , US  | 
| (73) | ChemoCentryx, Inc. ,
                835 Industrial Road, Suite 600, San Carlos, CA 94070,
                US | 
| (54) | PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5AR ANTAGONISTS | 
| PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5AR ANTAGONISTS |